Cited by 604Rheumatoid Arthritis Research and TherapiesAdrenal Hormones and DisordersPharmacovigilance and Adverse Drug Reactions

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Dose-related patterns of glucocorticoid-induced side effects

Huscher, D, Thiele, K, Gromnica-Ihle, E, Hein, G, Demary, W, Dreher, R, Zink, A, Buttgereit, F·2009·Annals of the Rheumatic Diseases

DOI 10.1136/ard.2008.092163

Open this paper in CoChat — free account

Abstract

Objective To identify patterns of self-reported health problems relating to dose and duration of glucocorticoid intake in unselected patients with rheumatoid arthritis from routine practice. Methods Data from 1066 patients were analysed. The clinical status and drug treatment were reported by the physician, health problems during the past 6 months by the patient using a comprehensive list of symptoms. Patients with ongoing glucocorticoid treatment for more than 6 months and current doses of less than 5, 5-7.5 and over 7.5 mg/day prednisone equivalent were compared with a group without any glucocorticoid treatment for at least 12 months. Results The frequency of self-reported health problems was lowest in the group without glucocorticoid exposition and increased with dosage. Two distinct dose-related patterns of adverse events were observed. A "linear" rising with increasing dose was found for cushingoid phenotype, ecchymosis, leg oedema, mycosis, parchment-like skin, shortness of breath and sleep disturbance. A "threshold pattern" describing an elevated frequency of events beyond a certain threshold value was observed at dosages of over 7.5 mg/day for glaucoma, depression/listlessness and increase in blood pressure. Dosages of 5 mg/day or more were associated with epistaxis and weight gain. A very low threshold was seen for eye cataract (<5 mg/day). Conclusion The associations found are in agreement with biological mechanisms and clinical observations. As there is a paucity of real-life data on adverse effects of glucocorticoids prescribed to unselected groups of patients, these data may help the clinician to adapt therapy with glucocorticoids accordingly and improve the benefit-risk ratio.

Integrity signals

Registry

Crossref · 10.1136/ard.2008.092163

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,753
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,742
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Polymyalgia Rheumatica and Giant-Cell Arteritis
Salvarani, C., Cantini, F., Boiardi, L., & Hunder, G. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011913 · Cited by 1,360
Risk of Infectious Complications in Patients Taking Glucocorticosteroids
Stuck, A. E., Minder, C. E., & Frey, F. J. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.6.954 · Cited by 833
The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis
Kirwan, J. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507203330302 · Cited by 817
Population‐based assessment of adverse events associated with long‐term glucocorticoid use
Curtis, J. R., Westfall, A. O., Allison, J., Bijlsma, J. W., Freeman, A., George, V., Kovac, S. H., Spettell, C. M., & Saag, K. G. (2006) · Arthritis Care & Research · doi:10.1002/art.21984 · Cited by 595
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology
Buttgereit, F., Da Silva, J. A. P., Boers, M., Burmester, G.-R., Cutolo, M., Jacobs, J., Kirwan, J., Köhler, L., van Riel, P., Vischer, T., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.8.718 · Cited by 544
Self-citation
Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events
Saag, K. G., Koehnke, R., Caldwell, J. R., Brasington, R., Burmeister, L. F., Zimmerman, B. M., Kohler, J. A., & Fürst, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90131-7 · Cited by 540

Show all 35 references

Research works printed but not linked: 1

Lautenschlaeger, 1997, [Comparative evaluation of a German version of the Health Assessment Questionnaire and the Hannover Functional Capacity Questionnaire], Z Rheumatol, 56, 144

Sorted by citations

Items 501–595 of 595

Impact of Drugs on Diabetes Risk and Glycemic Control
Frontoni, S., & Picconi, F. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_19
Current awareness: Pharmacoepidemiology and drug safety
(2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1846
Adjuvant analgesics
Portenoy, R. K., Ahmed, E., & Patel, M. (2021) · doi:10.1093/med/9780198821328.003.0042
Glaucoma Associated with Disorders of the Retina, Vitreous, and Choroid
Roa, T. M., Kanner, E. M., & Netland, P. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_158
Issues and Concerns in the Management of Progressive Allograft Dysfunction
Anandh, U., & Deshpande, P. (2022) · Indian Journal of Transplantation · doi:10.4103/ijot.ijot_114_20
Glucocorticoids
Heming, N., & Annane, D. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch58
Glucocorticoids
Jacobs, J. W. G., van der Goes, M. C., Bijlsma, J. W. J., & da Silva, J. A. P. (2020) · doi:10.1093/med/9780198831433.003.0029
Corticoterapia
de Chambrun, M. P., Wechsler, B., & Saadoun, D. (2013) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(13)64537-7
Steroids
Stasi, R. (2013) · doi:10.2217/ebo.12.125
Corticothérapie
de Chambrun, M. P., Wechsler, B., & Saadoun, D. (2013) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(12)49792-7
Oral Corticosteroids
Nakhla, E., & Gelot, S. R. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9194-1_558
Psoriasis in Children Treated With Anti-TNF-α Therapy for IBD
(2017) · AAP Grand Rounds · doi:10.1542/gr.37-5-58
Efficacy of two different dosages of prednisolone for treatment of subacute thyroiditis: a single-center, prospective, randomized, open-label, non-inferiority trialPreprint
Xu, Y., Liu, S., Zeng, X., Wu, Q., Chen, Y., He, C., Zhai, Q., Zhang, B., & Gao, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1756101/v1
Botulinum Toxin Treatment for Pain Indications in Veterinary Medicine
Jabbari, B. (2022) · Springer eBooks · doi:10.1007/978-3-030-99650-5_19
Efficacy of two different dosages of prednisone for treatment of subacute thyroiditis: a single-center, prospective, randomized, open-label, non-inferiority trialPreprint
Xu, Y., Zeng, X., Liu, S., Wu, Q., Chen, Y., He, C., Zhai, Q., Zhang, B., & Gao, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1899655/v1
A Narrative Review: Efficacy and Safety the Used of Corticosteroids as an Adjunct Therapy for Rheumatoid Arthritis
Herman, H., Hanifah, I. R., & Kamri, A. M. (2022) · International Journal of Public Health Excellence (IJPHE) · doi:10.55299/ijphe.v2i1.262
Corticoterapia en la práctica reumatológica
Nocturne, G. (2023) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(23)47692-1
Rheumatoid Arthritis
Deane, K. D., Aletaha, D., Bathon, J. M., Emery, P., Fragoulis, G. E., Holers, V. M., Huizinga, T. W. J., Kolfenbach, J., O’Dell, J. R., Pearson, D. W., et al. (2023) · Springer eBooks · doi:10.1007/978-3-031-23488-0_1
COVID-19 TEDAVİSİNİN NADİR YAN ETKİSİ: FEMUR BAŞI AVASKÜLER NEKROZU
Kaya, A., Erdem, H. A., Sabah, D., Yamazhan, T., & Tasbakan, M. I. (2023) · ANKEM Dergisi · doi:10.54962/ankemderg.1277280
Steroid glaucoma in patients with hemoblastosis
Smirnova, A. B., Першин, Б. С., & Myakova, N. V. (2023) · Russian Annals of Ophthalmology · doi:10.17116/oftalma202313902184
DETECCIÓN DEL SOBRECRECIMIENTO BACTERIANO DESDE LA FARMACIA COMUNITARIA
SERRANO, T. B. (2023) · doi:10.59466/lc12022cs2025
Efficacy of two different dosages of prednisone for treatment of subacute thyroiditis: a single-centre, prospective, randomized, open-label, non-inferiority trial
Xu, Y., Liu, S., Zeng, X., Wu, Q., Chen, Y., He, C., Zhai, Q., Zhang, B., & Gao, J. (2023) · Endokrynologia Polska · doi:10.5603/ep.a2023.0023
Effetti cardiovascolari dei farmaci glucocorticoidi: conosciamo veramente la Sindrome di Cushing esogena?
Voltan, G., Ceccato, F., & Scaroni, C. M. (2023) · L Endocrinologo · doi:10.1007/s40619-023-01317-3
“L’incidenza saliva al 9,1% per dosi >25 mg/die di PE, mentre dopo 5 anni di utilizzo di GC si registrava un’incidenza del 19,7% per dosi <5 mg/die PE e addirittura del 28% per dosi >25 mg/die [4].”
Background
Levothyroxine therapy in children with hypothyroidism due to frequently relapsing nephrotic syndrome: an observational cohort studyPreprint
Saberinejad, J., Taheri, A., Dormanesh, B., & Moghtaderi, M. (2023) · Research Square · doi:10.21203/rs.3.rs-3308700/v1
Systemic Lupus Erythematosus in a Patient with Liver Cirrhosis: Case Report and Literature Review
Hu, Y., & Hu, S. (2023) · Open Medicine Journal · doi:10.2174/18742203-v10-e230719-2022-49
การพฒนาอปกรณวเคราะหฐานกระดาษสำหรบหาปรมาณสารเพรดนโซโลนและเดกซาเมทาโซนทปลอมปนในผลตภณฑสมนไพรดวยวธเคมไฟฟา
พริ้มพราย, ว. (2018) · doi:10.58837/chula.the.2018.771
Reply to the letter to Editor – “Bioelectrical impedance analysis: Caution should be needed to avoid misinterpretation”
da Costa, M. S., Pontes, K. S. D. S., Guedes, M. R., Silva, M. I. B., & Klein, M. R. S. T. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.09.017
How Are Adjuvant Medications Such as Corticosteroids and NSAIDs Used for Pain Management?
Chilsen, A., Morphew, J., & Kamal, A. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-84702-5.00007-5
Diagnostic Value of Short Course Low-dose Prednisolone in Patients with Clinically Suspected Seronegative Inflammatory Arthritis - A Retrospective Study
Shan, S., & Mian, M. (2024) · Current Rheumatology Reviews · doi:10.2174/0115733971273652231213092458
Kutan depigmentering og subkutan atrofi efter peritendinøs kortikosteroidinjektion
Thomsen, L. J. L., Ejam, S., & Simonsen, A. B. (2024) · Ugeskrift for Læger · doi:10.61409/v72006
Infective endocarditis presentations during the COVID-19 pandemic: Have they paid an untold toll?
Elamragy, A. A., Samir, A., Maher, A., Rizk, H., & Mashaal, M. (2024) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2024.11
“If added to the susceptibility of COVID-19 patients to various systemic infections due to the liberal use of systemic steroids 25 , one can appreciate how the COVID-19 pandemic could have led to a surge in IE incidence.”
Background
A Retrospective Study of Children with Frequently Relapsing Nephrotic Syndrome Using Levothyroxine Added to Steroids During RelapsesPreprint
Saberinejad, J., Taheri, A., Dormanesh, B., & Moghtaderi, M. (2024) · Research Square · doi:10.21203/rs.3.rs-3308700/v2
Terapia corticosteroidea nella pratica reumatologica
Nocturne, G. (2024) · EMC - AKOS - Trattato di Medicina · doi:10.1016/s1634-7358(24)48829-3
A Retrospective Study of Children with Frequently Relapsing Nephrotic Syndrome Using Levothyroxine Added to Steroids During RelapsesPreprint
Taheri, A., Saberinejad, J., Dormanesh, B., & Moghtaderi, M. (2024) · Research Square · doi:10.21203/rs.3.rs-3308700/v3
Multiple Cutaneous Infections Secondary to Inadvertent Use of Systemic Steroids
Rana, G. S., Gupta, S., & Chopra, D. (2024) · Apollo Medicine · doi:10.1177/09760016241245246
Twenty First Century Treatments for a Nineteenth Century Disease: Polymyalgia Rheumatica
Rooney, J. K., & Rooney, P. J. (2024) · Annals of orthopedics and rheumatology. · doi:10.47739/2373-9290.orthopedics.1101
Glucocorticoid‐induced adrenal suppression: physiological basis and strategies for glucocorticoid weaning
Torpy, D. J., & Lim, W. T. (2024) · The Medical Journal of Australia · doi:10.5694/mja2.52299
Beyond the Nephron: Exploring Systemic Implications of Renal Tubular Acidosis
Coral, M. I. G. (2024) · JOJ Urology & Nephrology · doi:10.19080/jojun.2024.09.555751
Botulinum Toxin Therapy in Veterinary Medicine
Jabbari, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-54471-2_16
Cardiovascular risks of systemic corticosteroid therapy
Vymětal, J., & Horák, P. (2024) · Vnitřní lékařství · doi:10.36290/vnl.2024.073
CPD: Effect of Covid-19 on eye health
Clarkson, D. (2023) · Optician · doi:10.12968/opti.2023.267.6898.21
Immunosuppressive therapy of patients with pemphigus with ineffectiveness of systemic corticosteroids
Chikin, V. V., & Karamova, A. Е. (2024) · Vestnik dermatologii i venerologii · doi:10.25208/vdv16808
Explicit water-ligand docking, drug-likeness and molecular dynamics simulation analysis to predict the potency of Boerhavia diffusa plant extract against mutant wilms tumor-1 protein responsible for type 4 nephrotic syndrome
Sahu, S., Moharana, M., Das, A., Mishra, B., & Sahu, S. N. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2431649
Uso de corticosteroides na pneumocistose na população vivendo com HIV: temos opções?
Avelar, G. A. G., & Carranza-Tamayo, C. O. (2025) · Contribuciones a las Ciencias Sociales · doi:10.55905/revconv.18n.1-192
HF-Ultrasonography to Quantify Skin Atrophy in Patients with Inflammatory Rheumatic Diseases Treated with Courses of Glucocorticoids
Schuster, A. M., Horn, A., Günther, F., Fleck, M., HARTUNG, W. M., & Ehrenstein, B. P. (2025) · Diagnostics · doi:10.3390/diagnostics15050619
PULSE THERAPY WITH CORTICOSTEROIDS IN PATIENTS WITH MULTIPLE SCLEROSIS: ADVERSE EVENTS AND WAYS TO OVERCOME THEM
Vasylovskyi, V., Voloshyna, N., Nehreba, T., POHULIAIEVA, T., & Chernenko, M. (2024) · Ukrains kyi Visnyk Psykhonevrolohii · doi:10.36927/2079-0325-v32-is3-2024-3
Temporal prescribing trends in AIH: exploring the influence of early thiopurine use on corticosteroid dependency and biochemical response
Shah, S., Chung, Y., McKenzie, C., Morrison, M., & Heneghan, M. A. (2025) · Frontline Gastroenterology · doi:10.1136/flgastro-2025-103073
High-dose dexamethasone versus prednisone as first-line therapy in newly diagnosed immune thrombocytopenic purpura in children
Selim, A. E. N., Shamhout, H. M., Elkholy, R. A., Hagag, A. A. E., & Elaskary, E. M. (2025) · Alexandria Journal of Pediatrics · doi:10.4103/ajop.ajop_1_25
Corticosteroid-induced Cushingoid Appearance in Myasthenia Gravis
Uzawa, A., Suzuki, S., Kuwabara, S., Yasuda, M., Akamine, H., Onishi, Y., Ozawa, Y., Kawaguchi, N., Kubota, T., Takahashi, M. P., et al. (2025) · Internal Medicine · doi:10.2169/internalmedicine.5678-25
“One study found that the Cushingoid phenotype occurred in 4.3% of patients receiving a PSL dose of <5 mg/day, 15.8% of those receiving a dose of 5-7.5 mg/day, and 24.6% of those receiving a dose of >7.5 mg/day (11).”
Influential
Bioequivalence evaluation of dexamethasone palmitate injections by intravenous injection in healthy Chinese volunteers: a 2-period crossover trial
Wang, B., Huang, C., Xu, L., Fu, X., Ma, X., You, G., & Su, J. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04365-8
“…hypertension, obesity) (Bordag et al. 2015), skeletal abnormalities (osteoporosis) (Townsend & Saag 2004), cushing-like appearance (Chan & Tsoi 1994; Huscher et al. 2009), perineal burning sensation (Dylla et al. 2018), and suppression of the hypothalamic-pitu-itary axis (Yamamoto et al. 1998).”
Risk of intracranial hemorrhage in anti-neutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids: a systematic review of case reports
Achkar, A., Alhaddad, J. B., Naous, E., Ergin, S., & Jaber, B. L. (2025) · Rheumatology International · doi:10.1007/s00296-025-05924-1
“This relationship has been demonstrated in several studies, such as those by Huscher et al., who showed that higher doses of glucocorticoids increased the risk of epistaxis, likely due to impaired vascular integrity [59, 60].”
Remarkable Resolution of Radiation Necrosis Post-Obsessive-Compulsive Disorder Radiosurgery With Boswellia Serrata: Case Report
Upadhyay, R., Kumar, P., Singh, R. B., Raval, R. R., Palmer, J. D., & Thomas, E. (2025) · Advances in Radiation Oncology · doi:10.1016/j.adro.2025.101860
Arthritis as a risk factor for cataract: Evidence from NHANES data and Mendelian randomization
Ma, M., Yi, H., Zha, X., Kong, Y., Wu, G., Fan, X., Yuan, C., Song, R., & Zhang, Y. (2025) · Medicine · doi:10.1097/md.0000000000044600
“[14,31,32] However, the exact causality and underlying mechanisms of this association are yet to be elucidated, and further research is needed to explore these interactions and optimize diagnostic and therapeutic strategies for related diseases.”
The PREDMETH study of pulmonary sarcoidosis: Why did it take so long?
Judson, M. A. (2025) · Respiratory Medicine · doi:10.1016/j.rmed.2025.108443
Optic neuritis and risk of heart failure and atrial fibrillation: A nationwide cohort study
Kim, J., Kim, M.-S., Han, K., Jung, J.-H., Park, K.-A., & Oh, S. (2025) · PNAS Nexus · doi:10.1093/pnasnexus/pgaf312
“The typical corticosteroid regimen for acute ON involves relatively brief exposure (high-dose intravenous methylprednisolone for 3 – 5 days followed by a short oral taper) compared with chronic use typically associated with significant cardiovascular risk (50, 64).”
Precision medicine in myasthenia gravis
Mujawar, S., Gupta, S., Annam, T., Deshpande, A., & Prajapati, B. G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36647-5.00002-9
Single high-dose intramuscular injection versus short-term low-dose oral glucocorticoids as bridging therapy in active rheumatoid arthritis: a retrospective cohort study on remission induction
Ren, H., Ding, N., Yu, X., Teng, J., Cheng, X.-B., Ye, J., Su, Y., Shi, H., Hu, Q., Sun, Y., et al. (2025) · Clinical Rheumatology · doi:10.1007/s10067-025-07854-6
Additional file 1 of Late-onset rheumatoid arthritis has a similar time to remission as younger-onset rheumatoid arthritis: results from the Ontario Best Practices Research Initiative
Li, X., Cesta, A., Movahedi, M., & Bombardier, C. (2022) · Figshare · doi:10.6084/m9.figshare.21592502
Additional file 1 of Associations between vision impairment and multimorbidity among older Chinese adults: results from the China health and retirement longitudinal study
Xiong, K., Mao, H., Zhang, Q., Lei, C., & Liang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24431976
Allergic Rhinitis Therapy: Environmental, Pharmacotherapy, and Immunotherapy
Veling, M. C. (2025) · Springer eBooks · doi:10.1007/978-3-031-93455-1_6
Perspective Chapter: Effect of Azathioprine and Hydroxychloroquine in Reducing Steroids in Systemic Lupus Erythematosus
Jordhani, M., & Ruci, D. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1013760
Paraneoplastic Neurologic Disorders
Lang, B., Boston-Babicz, M., & Kamper, J. E. (2026) · Springer eBooks · doi:10.1007/978-3-032-05880-5_8
Exogenous (iatrogenic) Cushing syndrome: Most frequent uses of glucocorticoids and outcomes, including recommendations for recovery (postchemotherapy, asthma treatments, chronic use on rheumatoid, and/or skeletal disorders)
Vrachnis, D. N., & Stratakis, C. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-96100-4.00005-3
Effects of Chinese herbal medicine on reducing steroid-induced adverse reactions: A systematic review and meta-analysis from 1651 autoimmune disease patients in 18 randomized controlled trials
Fong, T.-L., Chen, G., Shen, C., Zhou, S., Xun, Y., Chen, Y., Zhang, C., Wang, N., Lau, C. S., & Feng, Y. (2026) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2026.100779
Effectiveness and Safety of Omalizumab in the Adjuvant Treatment of Patients With Refractory Acute Urticaria: A Real‐World Case–Control Study
Zhu, M., Xie, B. X. B., Pei, X., Zhang, Y., & Ye, Y. (2026) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.70117
Polysaccharide from Tetrastigma hemsleyanum Diels et Gilg attenuates acute lung injury induced by lipopolysaccharide associated with inhibiting complement and neutrophil activation
Guo, Y., Qi, Y., Zhou, F., Zhou, M., Li, X., Wang, Y., Chen, Y., & Ding, Z. (2026) · European journal of medical research · doi:10.1186/s40001-026-04067-8
Prednisone Avoidance After Abdominal Solid Organ Transplantation: A Narrative Review
Matar, A. J., Lake, J. R., Kandaswamy, R., & Matas, A. (2025) · Transplantation · doi:10.1097/tp.0000000000005572
抗凝固療法非施行にもかかわらず腹直筋血腫を呈したCOVID–19の1例(Rectus sheath hematoma in a COVID–19 patient without anticoagulation therapy: a case report)
真由, 近., HOSOGI, A., 奈保, 濱., 英佑, 濵., 暁, 濱., & Kito, E. (2026) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.1002/jja2.13119
Perturbations du métabolisme glucidique et azoté dans des modèles d'obésité induite par le régime hyperlipidique ou par les glucocorticoïdes
Do, T. T. H. (2016) · theses.fr (ABES) · doi:10.70675/e2af6462zcab6z4ff3z9101z1ed9a75555cc
Anti -IL-4, -IL-13 and -IgE vaccination for the treatment of allergic diseases
Conde, E. (2020) · theses.fr (ABES) · doi:10.70675/595ec855zeea2z4557z95b5z4de5bf043ffd
Implication de l'enzyme Glycogène Synthase Kinase 3 dans la médiation des effets diabétogènes des glucocorticoïdes
Delangre, E. (2021) · theses.fr (ABES) · doi:10.70675/622d48edz59dcz427ez85c9z9da5f8129e84
Delivery systems for treatment and diagnosis of inflammatory diseases
Libánská, A. (2023) · doi:10.70675/4b40d465z8423z4705z9e40z300c678eba9f
Efficacy and safety of tacrolimus combined with low-dose glucocorticoids vs. high-dose glucocorticoids in initial treatment of adult-onset minimal change disease: a retrospective cohort study
Ma, X., Li, J., Yang, X., Li, B., Yao, T., Tian, L., Lei, F., Yu, X., Naimova, S. A., Cao, S. L., et al. (2026) · PeerJ · doi:10.7717/peerj.21089
Prevalence and risk factors of herpes zoster in patients with rheumatoid arthritis: a systematic review and meta-analysis
Wang, S., Liu, Q., Zhou, P., Hu, W., & Liu, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1754915
“Furthermore, a meta-analysis conducted in Germany on GC-related adverse events (46) demonstrated that patients receiving prednisone at doses below 7.5 mg per day experienced fewer adverse events compared with those receiving doses above 7.5 mg per day.”
Influential
Association of steroid regimens and withdrawal with relapse risk in myasthenia gravis: a real-world cohort study
Huang, Y., Tan, Y. L., Yan, J., & Guan, Y. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1792705
Steroid use in glomerular diseases: Friend or foe?
Alghamdi, N. (2025) · Saudi Journal of Internal Medicine · doi:10.4103/sjim.sjim_38_25
Risk factors and critical thresholds for glucocorticoid-induced ocular adverse reactions in children: implications for muscle and neuromuscular disease management
Li, Y., Cui, T., Lin, Z. T., Zhao, L., Lai, Y., Yun, D., Lin, Z., Li, M., Huang, Y., Chen, S., et al. (2026) · European Journal of Translational Myology · doi:10.4081/ejtm.2026.15147
Skirtingos kūno masės asmenų kūno sudėties ir metabolinio aktyvumo parametrų sąsajos
Fomčenko, I. (2026) · doi:10.15388/vu.thesis.921
Abrocitinib for Erythema Multiforme-like Drug Eruptions
Chen, X.-Y., Wei, X.-Y., & Shi, B. (2026) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000002153
Perioperative management of dermatologic surgery patients on systemic cancer therapy
Trager, M. H., Gordon, E. R., Handfield, C., Kriplani, A., Smithy, J. W., Rossi, A., Lee, E., Nehal, K., & Connolly, K. L. (2026) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2026.06.126
Burden of Care
Goyal, N. (2026) · Current clinical neurology · doi:10.1007/978-3-032-19140-3_22
Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?
Spagnolo, P., & Miedema, J. (2026) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000001293
Risk factors for adverse events or use of high-potency corticosteroids in non-infectious uveitis: a Japan claims database study (J-CAT2)
Kusuhara, S., Sonoda, K., Kaburaki, T., Fujita, T., Katayama, S., Makishima, M., Nakamura, T., Nio, M., Omoto, T., Matsuo-Tezuka, Y., et al. (2026) · Immunological Medicine · doi:10.1080/25785826.2026.2693410
Low-dose, not low-risk: potential adrenal suppression identified by a risk-based approach to ACTH testing
Asano, R., Yamaguchi, S., Shinoda, K., Hounoki, H., Kido, T., Kawataka, M., Sugishita, N., Yamazaki, M., Okada, I., Kobiyama, A., et al. (2026) · Clinical Rheumatology · doi:10.1007/s10067-026-08284-8
“Glucocorticoid therapy is associated with multiple adverse effects, including infection, fracture, osteoporosis, and cataracts [1–3].”
Sarcoidosis: A Clinical Trials Perspective
Zapata-Huizi, J. J., Herrera, M., Poveda, J. J. R., Pérez‐Rodas, E. N., Hernández‐González, F., & Sellarés, J. (2026) · Pulmonary Therapy · doi:10.1007/s41030-026-00372-z
“How‑ ever, adverse effects associated with prolonged corticosteroid use, including osteoporosis, dia‑ betes mellitus, hypertension, and Cushing’s syndrome, have motivated the search for more specific and better‑tolerated therapeutic alterna‑ tives [6].”
Reduce My Prednisone? You Are My Doctor, and I Trust Everything You Do for Me!
Li, Y., & Shelly, S. (2026) · Springer eBooks · doi:10.1007/978-3-032-28877-6_5
Early recognition, prevention, and management of glucocorticoid toxicity in patients with rheumatic diseases
Cohen, L., Tiwari, V., Tesser, J., & Bergman, M. J. (2026) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2026.2718746
Glucocorticoid Treatment for Uveitic Macular Edema
黄, 澳. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1693119
Network meta-analysis of intrathyroidal injection of combined dexamethasone with lidocaine for subacute thyroiditis
Wei, H., Huang, Y., & Li, B. (2026) · Medicine · doi:10.1097/md.0000000000050821
Management of Autoimmune Hemolytic Anemias
Anani, W. Q., & Denomme, G. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-22427-0.00010-x
Implementing routine glucocorticoid toxicity monitoring: a multilevel, theory informed qualitative study with three pillars of behaviour changes recommendations for clinical teamsPreprint
Vasiliou, V. S., Ewing, C., Martins-Martinho, J., Lopes, A. R., Mackie, S. L., Ponte, C., & Luqmani, R. A. (2026) · Research Square · doi:10.21203/rs.3.rs-10606185/v1
Localized lymphoid hyperplasia with prominent IgG4-positive plasma cells in the inferior turbinate mimicking IgG4-related disease
Han, D. H., Jung, J. I., Kim, J. Y., Koh, J., Park, J. W., Lee, E. B., & Park, J. K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1898657
Corticosteroid Exposure in Autoimmune Hepatitis: Early Toxicity, Cumulative Burden and Associations With Long‐Term Patient‐Reported Outcomes
GENTRY, E., Woods, M., Green, K., Blessing, N., & Lammert, C. S. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.71044
Efficacy of auricular bloodletting therapy for acute urticaria
Xu, L., Xu, X., Han, Y., Ju, R., Wang, Y., Wu, X., Zhou, J., & Cao, Y. (2026) · Medicine · doi:10.1097/md.0000000000051145
Nanomaterial-based therapeutic strategies for systemic autoimmune rheumatic diseases: from molecular mechanisms to preclinical translation
Guo, H., Xiang, W., Zeng, L., Xiao, W., & Sun, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1981246
“Glucocorticoids illustrate a treatment-speci ﬁ c trade-off: they can control acute in ﬂ ammation effectively, while prolonged exposure may produce dose-and duration-related adverse events, supporting steroid-sparing strategies where clinically feasible (6, 16).”

Authors: Huscher, D., Thiele, K., Gromnica-Ihle, E., Hein, G., Demary, W., Dreher, R., Zink, A., & Buttgereit, F.
Affiliations: German Rheumatism Research Centre (DE)
Jena University Hospital (DE)
Charité – Universitätsmedizin Berlin (DE)
Corresponding author: Huscher, D
ORCID: Huscher, D
Thiele, K
Zink, A
Buttgereit, F
Venue: Annals of the Rheumatic Diseases
Publisher: Elsevier BV
Published: 2009-07
Volume: 68
Issue: 7
Pages: 1119-1124
ISSN: 0003-4967 (ISSN-L)
DOI: 10.1136/ard.2008.092163
OpenAlex: W2167459187
Cited by: 604
References: 35
Citations by year: 2026: 43 · 2025: 55 · 2024: 67 · 2023: 55 · 2022: 47 · 2021: 41 · 2020: 49 · 2019: 38 · 2018: 27 · 2017: 28 · 2016: 32 · 2015: 21 · 2014: 26 · 2013: 28 · 2012: 19
FWCI: 6.18
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Annals of the Rheumatic Diseases (publishedVersion)
PubMed (publishedVersion)
HighWire Press Open Archive (submittedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords: glucocorticoid adverse effects, dose-response relationship, rheumatoid arthritis, prednisone-equivalent dose, glaucoma, cataract, depression, hypertension, weight gain, bruising, lower limb edema, fungal infection, sleep disorders, risk-benefit ratio, threshold dose
MeSH terms: Arthritis, Rheumatoid, Data Collection, Dose-Response Relationship, Drug, Female, Glucocorticoids, Humans, Male, Middle Aged, Risk Factors, Time Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dose-related patterns of glucocorticoid-induced side effects

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks